MRNA — Moderna Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Moderna, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,608	10,727	9,902	8,604	7,025
Net Total Accounts Receivable
Net Total Receivables	1,411	3,296	1,664	1,081	592
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6,298	16,071	13,431	10,325	8,099
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	387	1,383	2,139	2,658	2,955
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	7,337	24,669	25,858	18,426	14,142
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4,389	9,128	4,923	3,015	2,206
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	4,775	10,524	6,735	4,572	3,241
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	2,561	14,145	19,123	13,854	10,901
Total Liabilities & Shareholders' Equity	7,337	24,669	25,858	18,426	14,142
Total Common Shares Outstanding